Access and affordability for all

Michael Sherman ()

Nature, 2018, vol. 564, issue 7735, S23-S23

Abstract: The hope of gene therapy could be crushed by its financial burden unless there are more rational ways of paying for it, says Michael Sherman.

Keywords: Gene therapy; Health care; Policy; Drug discovery (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/d41586-018-07648-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:564:y:2018:i:7735:d:10.1038_d41586-018-07648-8

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-018-07648-8

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().